🇺🇸 FDA
Patent

US 12104181

Compositions and methods for treating viral infections targeting TRIM7

granted A61KA61K48/0066A61K9/5123

Quick answer

US patent 12104181 (Compositions and methods for treating viral infections targeting TRIM7) held by The Board of Regents of the University of Texas System expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K48/0066, A61K9/5123, A61P, A61P31/14